首页> 外国专利> HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH IMPROVED CLINICAL OUTCOME

HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH IMPROVED CLINICAL OUTCOME

机译：肿瘤抗原特异性主动免疫治疗对肿瘤抗原的免疫反应及其与改善的临床结果的关系

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to compositions and methods for predicting treatment results by measuring a patient''s response to a cell''s antigen-specific active immunotherapy (CASAI) using a given biomarker.

机译：本发明涉及通过使用给定的生物标记物测量患者对细胞的抗原特异性主动免疫疗法（CASAI）的反应来预测治疗结果的组合物和方法。

著录项

公开/公告号KR102122601B1

专利类型
公开/公告日2020-06-12

原文格式PDF
申请/专利权人 덴드레온 파마슈티칼즈 엘엘씨;
展开▼

申请/专利号KR20167008895
发明设计人 구하다쿠르타 데브라이;트래거 제임스;세이크 나딤;
展开▼

申请日2014-09-05
分类号G01N33/68;A61K39;G01N33/564;G01N33/574;G01N33/58;G16C10;
国家 KR
入库时间 2022-08-21 11:04:26

相似文献

专利
外文文献
中文文献